within Pharmacolibrary.Drugs.ATC.J;

model J01DD06
  extends Pharmacokinetic.Models.PK_2C(
    weight         = 70,
    F              = 1,
    Cl             = 9.333333333333333e-05,
    adminDuration  = 600,
    adminMass      = 1000 / 1000000,   // mg → kg
    adminCount     = 1,
    Vd             = 0.0101,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,            
    Vdp             = 0.0072,
    k12             = 15.6,
    k21             = 15.6
    
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>J01DD06</td></tr><td>route:</td><td>intravenous</td></tr><tr><td>n-compartments</td><td>2</td></tr></table><p>Latamoxef (moxalactam) is a beta-lactam antibiotic belonging to the oxacephem class. It was previously used for the treatment of various bacterial infections, including respiratory tract infections, urinary tract infections, and septicemia. Due to concerns regarding adverse events like bleeding disorders and the availability of safer alternatives, latamoxef is rarely used and is not widely approved in clinical practice today.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters reported in healthy adult volunteers after single intravenous administration.</p><h4>References</h4><ol><li><p>de Louvois, J, et al., &amp; Mulhall, A (1984). Latamoxef and the newborn. <i>Archives of disease in childhood</i> 59(4) 346–350. DOI:<a href=\"https://doi.org/10.1136/adc.59.4.346\">10.1136/adc.59.4.346</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/6721561/\">https://pubmed.ncbi.nlm.nih.gov/6721561</a></p></li><li><p>Polk, RE, et al., &amp; Markowitz, SM (1981). Cefazolin and moxalactam pharmacokinetics after simultaneous intravenous infusion. <i>Antimicrobial agents and chemotherapy</i> 20(5) 576–579. DOI:<a href=\"https://doi.org/10.1128/AAC.20.5.576\">10.1128/AAC.20.5.576</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/6459759/\">https://pubmed.ncbi.nlm.nih.gov/6459759</a></p></li><li><p>Balant, L, et al., &amp; Auckenthaler, R (1985). Clinical pharmacokinetics of the third generation cephalosporins. <i>Clinical pharmacokinetics</i> 10(2) 101–143. DOI:<a href=\"https://doi.org/10.2165/00003088-198510020-00001\">10.2165/00003088-198510020-00001</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/3888488/\">https://pubmed.ncbi.nlm.nih.gov/3888488</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end J01DD06;
